Dados do Trabalho

Título

Application of SARC-F to sarcopenia screening in patients with Parkinson's disease in a specialized outpatient clinic in Fortaleza

Resumo

INTRODUCTION: Parkinson's disease (PD) is characterized by progressive and disabling neurodegeneration. Among the disorders present in PD, musculoskeletal alterations, such as sarcopenia, added to the decline in functional capacity, can favor fall events and reduced functionality and quality of life of PD patients. OBJECTIVE: Describe data obtained in screening for sarcopenia in patients with PD. METHODOLOGY: A descriptive observational study was carried out, applying the SARC-F Questionnaire in 125 patients with PD in a specialized outpatient clinic of a tertiary hospital in Fortaleza. The questionnaire evaluates the patient’s perception of their limitations in the following conditions: strength to lift and carry 4.5 kg; ability to walk around a room; get up from a chair; climb a flight of stairs and the number of falls in the last year. Results greater than or equal to 4 mean probable sarcopenia. Only patients with Hoehn & Yahr (HY) 1 to 3 were included and patients with any other disabling diseases were excluded. RESULTS: A total of 125 patients were analyzed, 72 (57.6%) male, with a mean age of 66.16 years. Of the total, the vast majority (42.4%) had HY of 2.5. Furthermore, 64 (51.2%) scored SARC-F positive, of which 33 (51.6%) were female and 31 (48.4%) were male, and 61 (48.8%) scored negative, of which 20 (33.3%) were female and 40 (66.7%) were male. Moreover, among the patients with positive SARC-F, 19 (29.7%) used some walking aid and 45 (70.3%) did not. Among the patients with negative SARC-F, 7 (11.5%) used some walking aid and 54 (88.5%) did not. Finally, among the total number of patients, 52 (41.6%) practiced physical activity for at least 30 minutes 3 times a week, of which 16 (30.8%) had positive SARC-F and 36 (69.2%) negative, and 73 (58.4%) did not practice physical activity, of which 48 (65.8%) had positive SARC-F and 25 (34.2%) negative. CONCLUSION: There is still few data in the literature that discriminate regarding the difference of sarcopenia screening in patients with PD, making more studies necessary for an adequacy of this analysis for this profile of patients.

Palavras Chave

Parkinson Disease, Sarcopenia, Diagnostic Screening Programs